William Hood

Director / Executive Committee

William Hood

Mr. Hood is a Founding Partner and the CEO of William Hood & Company, a differentiated industry-focused investment bank covering the Consumer, Food and Retail sectors.

Mr. Hood is well-known globally as a leading investment banker and investor in the Health & Wellness and Nutrition industries having been involved in many of the larger and better-known transactions including the sale of Liquid I.V. to Unilever, the sale of OLLY to Unilever, the sale of Atrium (Garden of Life) to Nestle for $2.3 billion, the sale of the Nature’s Bounty Company from Carlyle to KKR for $3 billion, the sale of UK-based Holland & Barrett to Letter1 Retail for $2.4 billion, the sale of Schiff to Reckitt Benckiser for $1.45 billion and the sale of Emergen-C to Pfizer.

Widely regarded as an expert in the industry, Mr. Hood is frequently invited to speak at key Health and Wellness conferences including Expo West, Expo East, the NBJ Summit, Supply Side West and ACG. Mr. Hood is also a contributor to both financial and industry publications and has been published or quoted about industry trends and matters of finance in the Wall Street Journal, CNBC, Bloomberg News, WWD and Reuters among others. Mr. Hood serves on the Editorial Board of the Nutrition Business Journal.

Mr. Hood has a global network and travels frequently to Europe and Asia. He grew up in the U.K. and Hong Kong and holds a B.S. from Georgetown University.

Mr. Hood serves on the Board of Directors of Vitamin Angels, the Board of Trustees of Vitamin Angels U.K. and the Board of Greenwich Emergency Medical Services in Greenwich, CT.